{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:52:33Z","timestamp":1788871953606,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ad Futura-Scientific and Educational Foundation of the Republic of Slovenia"},{"name":"MEDICOM, Bijeljina, Republic of Srpska, Bosnia and Herzegovina"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.clinbiochem.2013.06.006","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T16:08:31Z","timestamp":1371744511000},"page":"1526-1531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: Pleiotropic evidence from plasma mRNA analyses"],"prefix":"10.1016","volume":"46","author":[{"given":"Bosa","family":"Mirjanic-Azaric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubomir","family":"Sormaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darja","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snezana","family":"Uletilovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snezna","family":"Sodin-Semrl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Lakota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Artenjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janja","family":"Marc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Cerne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2007.11.004","article-title":"Pleiotropic effects of statin therapy: molecular mechanisms and clinical results","volume":"14","author":"Wang","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0010","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2004.07.003","article-title":"Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients","volume":"177","author":"Ascer","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0021-9150(03)00193-X","article-title":"Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolemia treated with atorvastatin","volume":"169","author":"Nawawi","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/clc.21017","article-title":"Effect of 40mg versus 10mg of atorvastatin on oxidized low-density lipoprotein, high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy","volume":"35","author":"Huang","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2005.10.015","article-title":"Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranylisoprenoid pathway in human endothelial cells and macrophages","volume":"188","author":"Veillard","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-8981(03)00321-8","article-title":"Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome","volume":"338","author":"Xu","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0021-9150(01)00469-5","article-title":"HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels","volume":"159","author":"Martinez-Gonzalez","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins \u2014 basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.11613\/BM.2011.039","article-title":"Increased DAPK1 but decreased CCL2 plasma levels of nucleic acids in patients with stable angina","volume":"21","author":"Cerne","year":"2011","journal-title":"Biochem Med (Zagreb)"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0055","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.clinbiochem.2010.09.017","article-title":"Increased plasma levels of CATS mRNA but not CATB mRNA in patients with coronary atherosclerosis","volume":"43","author":"Stern","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0060","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clinbiochem.2011.01.003","article-title":"CTSS activation coexists with CD40 activation in human atheroma: evidence from plasma mRNA analysis","volume":"44","author":"Cerne","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0065","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0070","first-page":"90","article-title":"Optimisation of methods for quantifying plasma mRNA levels from genes responsible for coronary artery plaque development and destabilization","volume":"8","author":"Cerne","year":"2011","journal-title":"Med Glas (Zenica)"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2 (\u2013Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0085","series-title":"Using multivariate statistics","author":"Tabachnick","year":"2007"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2008.11.032","article-title":"Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study","volume":"205","author":"Ostad","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0095","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.jacc.2008.11.002","article-title":"Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?","volume":"52","author":"Stein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0100","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ahj.2007.02.029","article-title":"Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration","volume":"153","author":"Blanco-Colio","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.108.813311","article-title":"Evidence for statinpleiotropy in humans: differential effects of statins and ezetimibe on Rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation","volume":"119","author":"Liu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.109.856666","article-title":"Letter by Tershakovec et al regarding article, \u201cEvidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation\u201d","volume":"120","author":"Tershakovec","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/cs1040189","article-title":"Levels of adhesion molecules do not decrease after 3months of statin therapy in moderate hypercholesterolemia","volume":"104","author":"Jilma","year":"2003","journal-title":"Clin Sci"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0120","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.metabol.2005.04.008","article-title":"The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia","volume":"54","author":"Takebayashi","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thromres.2011.09.027","article-title":"Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study","volume":"129","author":"Mobarrez","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbrc.2004.05.127","article-title":"Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway","volume":"320","author":"Tramontano","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1160\/TH07-12-0760","article-title":"Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent","volume":"100","author":"Diamant","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2006.02.009","article-title":"Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells","volume":"190","author":"Landsberger","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00005344-200302000-00022","article-title":"Effect of atorvastatin on adhesive phenotype of human endothelial cells activated by tumor necrosis factor alpha","volume":"41","author":"Bernot","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2009.04.034","article-title":"Shear stress preconditioning modulates endothelial susceptibility to circulating TNF-alpha and monocytic cell recruitment in a simplified model of arterial bifurcations","volume":"207","author":"Cicha","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/CH-2011-1450","article-title":"Shear stress patterns affect the secreted chemokine profile in endothelial cells","volume":"50","author":"Urschel","year":"2012","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1734-1140(09)70004-0","article-title":"ICAM-1 signaling in endothelial cells","volume":"61","author":"Lawson","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1749-6632.2001.tb03869.x","article-title":"Circulating nucleosomes in serum","volume":"945","author":"Holdenrieder","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinbiochem.2013.06.006_bb0170","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2007.06.057","article-title":"Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial","volume":"50","author":"de Lemos","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201300283X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201300283X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:42:25Z","timestamp":1757864545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991201300283X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":34,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S000991201300283X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.06.006","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: Pleiotropic evidence from plasma mRNA analyses","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}